Stay up-to-date on the latest industry, member, and policy related news.
MichBio members can submit news to be shared here, on our social media, and in our monthly newsletter.
Rep. Jason Morgan (D- MI-23) introduced HB 4167 late February, the latest attempt to establish a Rare Disease Advisory Council (RDAC) in Michigan. A RDAC would empower rare disease patients as partners in helping to shape policy development relevant to the unmet needs, common struggles, and concerns on equitable, quality, and affordable access to specialty…
The House Financial Services Committee, in a marathon session late April, considered a package of 15 bills designed to relieve regulatory burdens and facilitate access to needed capital for biotech startups. Among them were the following: The Equal Opportunity for All Investors Act,which would create a certification exam to qualify as an accredited investor so more…
Reps. Buddy Carter (R-GA) and Carol Miller (R-WV) reintroduced the Manufacturing API, Drugs, and Excipients (MADE) In America Act to prevent U.S. pharmaceutical supply chain dependence on China and other foreign adversaries. The MADE in America Act will stimulate domestic manufacturing of drugs and pharmaceutical supplies such as active pharmaceutical ingredients (API) and personal protective…
The Senate HELP Committee is taking up four bills – S 1607 (Ensuring Timely Access to Generics Act of 2023), S 1214 (Retaining Access and Restoring Exclusivity Act of 2023), S 1114 (Expanding Access to Low-Cost Generics Act of 2023), and S 1339 (Pharmacy Benefit Manager Reform Act) – introduced with a focus on regulating drug…
Medical device sterilizers will face new limits on ethylene oxide (EtO) emissions and new requirements for worker protection, according to a pair of proposals issued by the EPA. The new limits are part of a broader series of actions by the agency to reduce exposure to the chemical, which it said can increase cancer risks…
The America Innovation and R&D Competitiveness Act of 2023 was reintroduced that would repeal current rules and allow a business to deduct of R&D costs in the tax year that they occur and thereby incentivize long-term investments in innovation. Such repeal has been a top policy priority for MichBio and the bio-industry generally as it would…
Spring in Washington, DC annually witnesses the ritual of Legislative Fly-Ins whereby many special interest groups descend on Capitol Hill to advocate their policy priorities. This year was no different, except for the fact that it was the first time such pilgrimages were made in three years due to the pandemic. MichBio made two trips…
MichBio, like many other stakeholders in the life sciences industry, has serious concerns over the recent Texas Court decision to suspend the FDA approval of abortion pill mifepristone and what it may mean more broadly for the FDA’s ability to regulate drug reviews and approval. The decision, should it stand upon appeal, would set a…
ORIGINAL SOURCE ANN ARBOR, MI, APRIL 26, 2023—Cayman Chemical and the Centers for Disease Control and Prevention (CDC) have released a new addition to the Traceable Opioid Material® Kits (TOM Kits®) product line that expands testing laboratory capabilities beyond synthetic opioids to include additional emerging drugs of abuse that are commonly found as co-drugs in fentanyl-containing samples. The new Fentanyl…
ORIGINAL SOURCE WASHINGTON, D.C. – The Environmental Protection Agency (EPA) today released its proposed rule regulating ethylene oxide (EtO) sterilizers of medical technology and other commercial uses through the National Emission Standards for Hazardous Air Pollutants (NESHAP) under the Clean Air Act. The EPA also released its proposed update of EtO registration as a sterilant under the…
CANTON, Mich. (3/21/2023) – MMS Holdings, an award-winning, data-focused CRO, announced today the addition of Dr. Philip Breitfeld and Dr. Bernhardt Zeiher to its board of scientific advisors. Both industry leaders in innovative clinical trial delivery solutions, Dr. Breitfeld and Dr. Zeiher’s additions as advisors expand MMS’ therapeutic area expertise to support growth in different…
ORIGINAL SOURCE When it comes to long COVID, health care providers and the biotech industry must be aware of what is already known, but we still need to learn much more, participants at an online long COVID webinar co-organized by the Biotechnology Innovation Organization (BIO) were told yesterday. “While significant research efforts by the U.S.…
CANTON, Mich. (February 21, 2023) – MMS Holdings, a data-focused contract research organization (CRO) – announced its partnership with the Institute for Advanced Clinical Trials (I-ACT) to accelerate the development of life-saving therapeutics, including vaccines, medicines, and medical devices for children. MMS is a sponsor of I-ACT’s Spin Challenge, a creative way to raise funds to…
Giving a voice to the one million Michiganders with a rare disease. February 27, 2023 – Lansing, MI – Representative Jason Morgan (D) Ann Arbor to introduce legislation to establish a Rare Disease Advisory Council (RDAC) in Michigan. The council will gather stakeholders from the patient community, the life sciences industry, health insurance, provider…
The NHLBI Phase IIB Bridge (RFA-HL-23-009) and Small Market Award (RFA-HL-23-008) Programs can provide up to $3 Million over three (3) years to continue the commercialization of novel products in the NHLBI mission space, specifically towards the completion of milestones necessary to achieve regulatory approval. This work must represent an extension of work completed under an…